Literature DB >> 11123064

Clinical trials for the antiphospholipid syndrome.

J T Merrill1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11123064     DOI: 10.1007/s11926-000-0084-9

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  57 in total

1.  Functional diagnosis of activated protein C resistance in patients with antiphospholipid antibodies.

Authors:  J Aznar; P Villa; F España
Journal:  Clin Appl Thromb Hemost       Date:  1999-04       Impact factor: 2.389

2.  Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor.

Authors:  M Galli; P Comfurius; C Maassen; H C Hemker; M H de Baets; P J van Breda-Vriesman; T Barbui; R F Zwaal; E M Bevers
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

3.  Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant.

Authors:  E Marciniak; E H Romond
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

4.  Inhibition of protein S by autoantibodies in patients with acquired protein S deficiency.

Authors:  M Sorice; P Arcieri; T Griggi; A Circella; R Misasi; L Lenti; G D Di Nucci; G Mariani
Journal:  Thromb Haemost       Date:  1996-04       Impact factor: 5.249

5.  Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?

Authors:  M Weber; G Hayem; M De Bandt; B Seifert; E Palazzo; S Roux; M F Kahn; O Meyer
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

6.  Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus.

Authors:  J S Ginsberg; C Demers; P Brill-Edwards; R Bona; M Johnston; A Wong; J A Denburg
Journal:  Am J Med       Date:  1995-04       Impact factor: 4.965

7.  Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry.

Authors:  G Finazzi; V Brancaccio; M Moia; N Ciaverella; M G Mazzucconi; P C Schinco; M Ruggeri; E M Pogliani; G Gamba; E Rossi; F Baudo; C Manotti; A D'Angelo; G Palareti; V De Stefano; M Berrettini; T Barbui
Journal:  Am J Med       Date:  1996-05       Impact factor: 4.965

8.  [Anti-beta 2 glycoprotein I antibodies in systemic lupus erythematosus: a marker of thrombosis associated with a circulating anticoagulant].

Authors:  J P Viard; Z Amoura; J F Bach
Journal:  C R Acad Sci III       Date:  1991

Review 9.  The superfamily of C3b/C4b-binding proteins.

Authors:  T Kristensen; P D'Eustachio; R T Ogata; L P Chung; K B Reid; B F Tack
Journal:  Fed Proc       Date:  1987-05-15

Review 10.  Management of thrombosis and pregnancy loss in the antiphospholipid syndrome.

Authors:  M A Khamashta
Journal:  Lupus       Date:  1998       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.